-
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
-
Prostate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
-
Dr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
-
Dr. Bernard Fox honored for his lifetime contributions to cancer research
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
-
Can these new studies offer hope for people with lung and head and neck cancers?
A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.
-
Cancer survivor speaks with doctor he credits for saving his life
Cancer survivor Mark Williams chats with Dr. Brendan Curti about
-
2024 Hood to Coast Relay: Providence team captains tell us why they run
What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.
-
Promising advances in treating TNBC: Two studies offer hope
Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.
-
Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
-
The evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
-
Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
-
Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
-
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
-
Celebrating World Immunology Day
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
-
New vaccine being studied for HPV+ head and neck cancer
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
-
Celebrating our oncology social workers
In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.
-
Talking to an expert: The crucial role of nutrition in cancer care
In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.
-
How promoting apoptosis in new study may help people with cancer
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
-
Dose-escalation studies aspire to fill gaps in cancer treatment options
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
-
FDA approves cellular therapy, offering hope to more people with cancer
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
- Loading More...